OMGA - Omega Therapeutics GAAP EPS of -$0.42 beats by $0.15 revenue of $0.27M May, 04 2022 05:45 PM Omega Therapeutics Inc. Omega Therapeutics press release (NASDAQ:OMGA): Q1 GAAP EPS of -$0.42 beats by $0.15. Revenue of $0.27M. For further details see: Omega Therapeutics GAAP EPS of -$0.42 beats by $0.15, revenue of $0.27M